QCG
IOVA icon

Quadrant Capital Group’s Iovance Biotherapeutics IOVA Stock Holding History

Quadrant Capital Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,316
Closed -$8.13K – 1890
2026
Q1 		$8.13K Buy
+2,316
New +$7.41K ﹤0.01% 2246
2025
Q2 		– Sell
-4,712
Closed -$15.7K – 1959
2025
Q1 		$15.7K Sell
4,712
-347
-7% -$1.79K ﹤0.01% 2101
2024
Q4 		$37.4K Hold
5,059
– – ﹤0.01% 1577
2024
Q3 		$47.5K Hold
5,059
– – ﹤0.01% 1480
2024
Q2 		$40.6K Hold
5,059
– – ﹤0.01% 1511
2024
Q1 		$75K Hold
5,059
– – 0.01% 1153
2023
Q4 		$41.1K Buy
5,059
+4,678
+1,228% +$24.5K ﹤0.01% 1495
2023
Q3 		$1.73K Sell
381
-1,433
-79% -$9.36K ﹤0.01% 2423
2023
Q2 		$12.8K Buy
1,814
+130
+8% +$930 ﹤0.01% 1911
2023
Q1 		$10.3K Hold
1,684
– – ﹤0.01% 2014
2022
Q4 		$10.8K Buy
1,684
+1,552
+1,176% +$12.1K ﹤0.01% 1910
2022
Q3 		$1K Sell
132
-127
-49% -$1.47K ﹤0.01% 2522
2022
Q2 		$3K Sell
259
-22
-8% -$288 ﹤0.01% 2113
2022
Q1 		$4K Sell
281
-736
-72% -$11.4K ﹤0.01% 1975
2021
Q4 		$19K Buy
1,017
+244
+32% +$5.37K ﹤0.01% 1334
2021
Q3 		$19K Buy
773
+545
+239% +$12.8K ﹤0.01% 1261
2021
Q2 		$6K Buy
228
+161
+240% +$4.18K ﹤0.01% 1777
2021
Q1 		$2K Buy
67
+2
+3% +$83 ﹤0.01% 2074
2020
Q4 		$3K Buy
65
+31
+91% +$1.23K ﹤0.01% 1838
2020
Q3 		$1K Buy
+34
New +$1.04K ﹤0.01% 1996
2020
Q2 		– Sell
-150
Closed -$4K – 2305
2020
Q1 		$4K Buy
+150
New +$3.98K ﹤0.01% 1702

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Quadrant Capital Group's IOVA Position: Q2 2026 in Review

Quadrant Capital Group sold out of Iovance Biotherapeutics (IOVA) in Q2 2026, closing a stake of 2,316 shares — an estimated $8.13K sold.

Quadrant Capital Group first reported a position in IOVA in Q1 2020 and held it in 21 quarters. The position peaked at $75K in Q1 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Quadrant Capital Group reported no remaining Iovance Biotherapeutics position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 2,316 Iovance Biotherapeutics shares in Q2 2026, an estimated $8.13K.
  • Quadrant Capital Group first reported a position in Iovance Biotherapeutics in Q1 2020 and held it in 21 quarters.
  • Quadrant Capital Group's Iovance Biotherapeutics position peaked at $75K in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.